Crescita Therapeutics (TSX:CTX) FCF Margin % : 7.57% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Crescita Therapeutics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Crescita Therapeutics's Free Cash Flow for the three months ended in Mar. 2024 was C$0.38 Mil. Crescita Therapeutics's Revenue for the three months ended in Mar. 2024 was C$5.00 Mil. Therefore, Crescita Therapeutics's FCF Margin % for the quarter that ended in Mar. 2024 was 7.57%.

As of today, Crescita Therapeutics's current FCF Yield % is 3.87%.

The historical rank and industry rank for Crescita Therapeutics's FCF Margin % or its related term are showing as below:

TSX:CTX' s FCF Margin % Range Over the Past 10 Years
Min: -6114.47 Med: -10.67 Max: 35.48
Current: 1.8

During the past 10 years, the highest FCF Margin % of Crescita Therapeutics was 35.48%. The lowest was -6114.47%. And the median was -10.67%.

TSX:CTX's FCF Margin % is ranked better than
55.06% of 1028 companies
in the Drug Manufacturers industry
Industry Median: 0.06 vs TSX:CTX: 1.80

Crescita Therapeutics FCF Margin % Historical Data

The historical data trend for Crescita Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Crescita Therapeutics FCF Margin % Chart

Crescita Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

22.79

35.48

-11.59

-5.31

11.09

Crescita Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															46.31	1.57	4.12	-5.52	7.57

Competitive Comparison of Crescita Therapeutics's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Crescita Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Crescita Therapeutics's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Crescita Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Crescita Therapeutics's FCF Margin % falls into.

Crescita Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Crescita Therapeutics's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	1.943	/	17.522
	=	11.09 %

Crescita Therapeutics's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	0.378	/	4.996
	=	7.57 %

Crescita Therapeutics FCF Margin % Related Terms

Thank you for viewing the detailed overview of Crescita Therapeutics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Crescita Therapeutics (TSX:CTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Crescita Therapeutics Inc (TSX:CTX) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

CRRTF:USA

Address

2805, Place Louis-R-Renaud, Laval, QC, CAN, H7V 0A3

Website

https://www.crescitatherapeutics.com

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The company has three reportable segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The firm generates its revenue in the form of product sales and out-licensing revenue.

Executives

Knight Therapeutics Inc.

10% Security Holder

Crescita Therapeutics (TSX:CTX) Headlines

No Headlines